Delivery Order SPE2DB22D3011-SPE2DB25FQ2WS
- Not listed
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal procurement relationships,...
- The Defense Logistics Agency awarded a $41,916 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle supporting federal medical...
- The Defense Logistics Agency awarded a $1,676.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rabavert Rabies Vaccine with diluents, with a completion date of September 12, 2025. This non-set-aside contract represents a small-value transaction within the company's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary...
- The Defense Logistics Agency awarded a $30,134.91 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This is a firm fixed-price, non-set-aside contract with a completion date of April 9, 2025, issued on April 8, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a tactical procurement fulfilling immediate medical supply needs within...
- The Defense Logistics Agency awarded a $1,257.48 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 15, 2025. The contract is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $54,078.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of May 5, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a single procurement action under AmerisourceBergen's broader federal contract portfolio, which demonstrates...
- The Defense Logistics Agency awarded a delivery order valued at $2,095.80 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor and healthcare solutions provider. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,441.62 for Rabavert rabies vaccine with diluents under a firm fixed-price contract. This non-set-aside award, issued on July 29, 2025, represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a $2,816.02 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed price contract. The award, valued at $1,047.90, was competitively awarded with no set-aside designation and carries an ultimate completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's broader...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2WSDelivery Order
The Defense Logistics Agency awarded a $7,175.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of September 24, 2025. This non-set-aside contract represents a routine pharmaceutical procurement to support federal medical supply requirements. The award was issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters and primary distribution hub. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates significant capability across multiple therapeutic domains and delivery scales, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/23/25 |